Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/VA/Richmond
Updated July 2026 from ClinicalTrials.gov

Paid Clinical Trials in Richmond, VA

Studies commonly pay $75 to $4,500 per completed study

620 clinical trials are currently recruiting participants within 30 miles of Richmond. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

620studies recruiting
9+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Richmond right now

Top 25 of 620 recruiting studies, sorted by proximity — each links to its official registry page

Open Label, Controlled, Post Marketing, Registry Study of Ribociclib (Ribo) Treatment Adherence and Patient Reported Outcomes in Participants Using ReX Technology Platform

Any Solid Oral Medication N/A Interventional 200 participants sought
Virginia Cancer Center — Richmond, Virginia (1.9 mi) · Sponsor: Dosentrx Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT06344416)

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Neovascular Age-related Macular Degeneration Phase 4 Interventional 188 participants sought
Retina Institute of Virginia — Richmond, Virginia (1.9 mi) · Sponsor: Genentech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04853251)

Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis

Lewy Body Dementia Psychosis Phase 2 Interventional 180 participants sought
Virginia Commonwealth University (a public institution of higher education) — Richmond, Virginia (1.9 mi) · Sponsor: ACADIA Pharmaceuticals Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07029581)

The Vanguard Study: Testing a New Way to Screen for Cancer

Bladder Carcinoma, Breast Carcinoma N/A Interventional 24,000 participants sought
VCU Massey Cancer Center at Stony Point — Richmond, Virginia (1.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06995898)

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma Phase 2 Interventional 188 participants sought
VCU Massey Cancer Center at Stony Point — Richmond, Virginia (1.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04671667)

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Amyloidosis, Amyloid Cardiomyopathy Phase 3 Interventional 587 participants sought
Virginia Commonwealth University — Richmond, Virginia (1.9 mi) · Sponsor: Eidos Therapeutics, a BridgeBio company
See eligibility & contact on ClinicalTrials.gov (NCT06563895)

Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality

Acute Myeloid Leukemia Phase 4 Interventional 12 participants sought
Virginia Commonwealth University — Richmond, Virginia (1.9 mi) · Sponsor: Virginia Commonwealth University
See eligibility & contact on ClinicalTrials.gov (NCT06370000)

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

Relapsed Refractory Multiple Myeloma Phase 3 Interventional 508 participants sought
Research Site — Richmond, Virginia (1.9 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07391657)

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

Interstitial Lung Disease Phase 2 Interventional 25 participants sought
aTyr Investigative Site — Richmond, Virginia (1.9 mi) · Sponsor: aTyr Pharma, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05892614)

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Multiple conditions Phase 2 Interventional 150 participants sought
Virginia Cancer Institute — Richmond, Virginia (1.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05136196)

Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant

NAFLD Phase 2 Interventional 50 participants sought
Virginia Commonwealth University — Richmond, Virginia (1.9 mi) · Sponsor: University of Virginia
See eligibility & contact on ClinicalTrials.gov (NCT05424003)

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

Non-small Cell Lung Cancer Phase 3 Interventional 582 participants sought
Research Site — Midlothian, Virginia (9.6 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06350097)

Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma Phase 3 Interventional 380 participants sought
VCU Massey Cancer Center: Dalton Oncology Clinic /ID# 261944 — Richmond, Virginia (1.9 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06158841)

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Acute Myeloid Leukemia Phase 2 Interventional 93 participants sought
VCU Massey Comprehensive Cancer Center — Richmond, Virginia (1.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06672146)

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma Phase 3 Interventional 1,450 participants sought
Virginia Cancer Institute — Richmond, Virginia (1.9 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT04566328)

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Breast Neoplasms Phase 3 Interventional 558 participants sought
Bon Secours Cancer Institute at St. Mary's — Richmond, Virginia (1.9 mi) · Sponsor: BioNTech SE
See eligibility & contact on ClinicalTrials.gov (NCT07173751)

Associations Between Household Mold Levels and Physical and Mental Health: A Mold and Mycotoxin Testing Research Registry

Mold Illness, Mold or Dust Allergy N/A Observational 2,500 participants sought
OvationLab — Richmond, Virginia (1.9 mi) · Sponsor: OvationLab
See eligibility & contact on ClinicalTrials.gov (NCT07605078)

Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies

Advanced Solid Malignancies Phase 1, Phase 2 Interventional 111 participants sought
Virginia Commonwealth University — Richmond, Virginia (1.9 mi) · Sponsor: Georgiamune Inc
See eligibility & contact on ClinicalTrials.gov (NCT06028074)

Randomized Controlled Trial of Treatment to Optimize Heart Rate Variability for Persistent Post-Concussion Symptoms

Autonomic Nervous System Disease, Concussive Injury Phase 2, Phase 3 Interventional 148 participants sought
Virginia Commonwealth University — Richmond, Virginia (1.9 mi) · Sponsor: Virginia Commonwealth University
See eligibility & contact on ClinicalTrials.gov (NCT07071350)

Chest Drain Regular Flushing in Complicated Parapneumonic Effusions and Empyemas

Empyema, Pleural, Pleural Infection N/A Interventional 96 participants sought
Virginia Commonwealth University — Richmond, Virginia (1.9 mi) · Sponsor: Vanderbilt University Medical Center
See eligibility & contact on ClinicalTrials.gov (NCT06427538)

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features Phase 3 Interventional 600 participants sought
VCU Massey Cancer Center at Stony Point — Richmond, Virginia (1.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06337318)
Google-rated

Top-rated research centers in Richmond

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Clinical Trials of Virginia

6767 Forest Hill Ave #305, Richmond, VA 23225
(804) 330-9410

Wright Center for Clinical and Translational Research

1200 E Clay St, Richmond, VA 23298
(804) 827-1531

Clinical Research Partners

★ 4.9 (66 reviews)
7110 Forest Ave, Richmond, VA 23226
(804) 477-3045
"This was a really friendly environment. Piyali made the process very smooth and was so kind and friendly. Any worries I had she addressed and made me…"
— YoshiRocker 7, 5★

National Clinical Research

★ 5.0
2809 Emerywood Pkwy #140, Richmond, VA 23294
(804) 672-2995

VCU Medical Center - Laboratory

★ 2.0
401 N 13th St, Richmond, VA 23298
(804) 828-7284
"Called this number because it was listed publicly on Google and due to my lab results not being available 72 hours after the draw.. Person who answer…"
— Penny, 1★

CARI Center

203 E Cary St, Richmond, VA 23219
(804) 639-9267

Richmond City Health District

★ 3.4
400 E Cary St, Richmond, VA 23219
(804) 482-5500
"Everyone in the process was kind, professional, and very efficient. I was surprised to see how fast everything was to get tested. A huge resource for…"
— Isaiah Cabino, 5★

VCU Medical Center North Hospital

★ 3.3
1300 E Marshall St, Richmond, VA 23219
(804) 828-9000
"My wife gave birth at this hospital, and unfortunately, our experience was extremely traumatic due to what we believe was negligence by Dr. Amanda Ri…"
— Patrick Powell, 1★

Retreat Doctors' Hospital

★ 4.6
2621 Grove Ave, Richmond, VA 23220
(804) 254-5100
"The best hospital in Richmond..the staff treats you like family...the 5th floor is the greatest and these people care for you like you're their own: …"
— Sasha Foster, 5★

Clinical trials in Richmond: what's recruiting

The Richmond area currently has 620 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Richmond, the most active research areas are:

  • Cancer & Oncology10 studies
  • Heart & Vascular3 studies
  • Liver & Kidney1 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Richmond, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Richmond

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Richmond participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Richmond?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Richmond safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Richmond?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Richmond.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Richmond typically complete one or two studies per year.

Paid clinical trials near Richmond

Other metros within reach

Fredericksburg, VA34 Newport News, VA384 Alexandria, VA2,303 Norfolk, VA407 Arlington, VA2,345 Chesapeake, VA408 Washington, DC2,376 Virginia Beach, VA407

More of VA

Arlington2,345 Alexandria2,303 Chesapeake408 Virginia Beach407 Norfolk407 Newport News384 Roanoke200 Fredericksburg34

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts